Evidence map›Paper›PMID 35024752›Full record

ArticleRomanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie

Conventional grade 1 chondrosarcoma: a challenging diagnosis with important implications on therapy and prognosis.

Gabriel Veniamin Cozma, Laurenţiu Vasile Sima, Raluca Maria Cloşca, Flavia Baderca, Ioana Delia Horhat, Nicolae Constantin Balica, Alina Andreea Tischer, Ion Cristian Moţ, Daniel Claudiu Maliţa, Aurel Marin and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Isocitrate dehydrogenase mutations as potential tumour agnostic targets.EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.] · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Gabriel Veniamin CozmaDepartment of ENT, Victor Babeş University of Medicine and Pharmacy, Emergency City Hospital, Timişoara, Romania; deliahorhat@yahoo.com, flaviabaderca@gmail.com.
Laurenţiu Vasile Sima
Raluca Maria Cloşca
Flavia Baderca
Ioana Delia Horhat
Nicolae Constantin Balica
Alina Andreea Tischer
Ion Cristian Moţ
Daniel Claudiu Maliţa
Aurel Marin
Cristian Andrei Sarău
Victor Babeș University of Medicine and Pharmacy Timișoara · ROClinical Emergency Hospital Bucharest · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chondrosarcoma (CHS) is a malignant tumor of soft tissue with cartilaginous differentiation that represent one tenth of all malignant proliferations developed from bone tissues. Even if CHS represents the third malignancy with bone localization, after myeloma and osteosarcoma, it is far less diagnosed in the head and neck region. The current paper presented two cases of conventional CHSs, which were diagnosed in Department of Thoracic Surgery and Department of Otorhinolaryngology of Emergency City Hospital, Timişoara, Romania, between February and June 2021. The malignant cases were of peripheral CHSs, one of scapula, and the other one had an extremely rare tracheal location with microscopic features of conventional low-grade tumors (grade 1). In all cases, conservative surgical curative treatment was performed, with a favorable postoperative evolution.

Indexed as

Bone NeoplasmsChondrosarcomaOsteosarcomaHumansRomania

Identifiers

PMID35024752
PMCPMC8848212
OpenAlexW4205891391

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.